|
Version 4.0.200811 |
|
This is the complete description of the cell line that you requested.
By selecting a generic term (e.g. SPECIES) you will go to the corresponding list of controlled terms, while by selecting a specific term you will go to the list of corresponding cell line names.
SPECIES: human, Caucasian
TISSUE/ORGAN: lung
TUMOR: carcinoma
ECACC catalog code: 86012804
Morphology: Epithelial
Susceptibility to viruses: adenovirus
Description: Human Caucasian lung carcinoma
Viruses: See Properties
Depositor: Obtained from ATCC, USA
No restrictions. Patent: None Specified By Depositor
Properties: Products: Lecithin, High amounts of de-saturated fatty acids. Applications: Enzymatic studies
Available in the following LABORATORY:
-
Part of the Business Division of the Health Protection Agency (ECACC, Salisbury, Wiltshire)
Ham's F12K or DMEM + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.
Passages: 85;
Karyotype: Hypotriploid
Derived from a 58 year old Caucasian male. The cells can synthesise lecithin utilising the cytidine diphosphocholine pathway. Occasional cells may also contain inclusion bodies although they are not known to carry any human pathogen.
Research council deposit: No;
Price Code: A;
Validated by: isoenzymes (species confirmation)
Availability in cell line catalogues: ATCC: CCL 185, ICLC: HTL03001, IZSBS: TCL 101
Bibliographic references:
- Biochem J 1993;294(1):49-55 - PMID: 8395818
- Biochem Soc Trans 1992;20(2):136S
- Brain Res 1992;583(1-2):100-104 - PMID: 1324089
- Carbohydr Res 1992;234:237-346 - PMID: 1334801
- Eur J Pharmacol 1990;184(2-3):233-238 - PMID: 1964127
- Eur J Pharmacol 1991;208(3):265-268 - PMID: 1685127
- FASEB J 1993;7(14):1376-1380 - PMID: 8224610
- FEBS Lett 1990;260(1):91-94 - PMID: 2153579
- Int J Cancer 1976;17:62-70 - PMID: 175022
- J Biol Chem 1990;265(36):22282-22287 - PMID: 2176212
- J Biol Chem 1991;266(12):7876-7882 - PMID: 1902229
- J Biol Chem 1991;266(13):8431-8438 - PMID: 2022658
- J Biol Chem 1991;266(30):20519-20524 - PMID: 1657928
- J Biol Chem 1993;268(26):19411-19415 - PMID: 8396137
- J Natl Cancer Inst 1973;51:1417-1423 - PMID: 4357758
- J Neurochem 1991;57(3):963-969 - PMID: 1650398
- J Neurochem 1993;61(2):12-17 - PMID: 8515256
- J Pharmacol Exp Ther 1990;253(1):185-191 - PMID: 2329505
- J Pharmacol Exp Ther 1993;264(3):1121-1127
- Mol Cell Biol 1992;12(10):4742-4750 - PMID: 1328861
- Mol Pharmacol 1990;37(2):296-303 - PMID: 1689454
- Mol Pharmacol 1991;39(3):399-406 - PMID: 1706472
- Mol Pharmacol 1993;44(2):364-370 - PMID: 8394993
- Naunyn Schmiedebergs Arch Pharmacol 1992;346(1):51-56 - PMID: 1407005
- Nippon Yakurigaku Zasshi 1992;99(1):1-11 - PMID: 1313776
- Prostaglandins 1990;40(4):405-416 - PMID: 91126216
- Symp Soc Exp Biol 1990;44:147-156 - PMID: 2130511
See also
For information, get in touch with:
Istituto Nazionale per la Ricerca sul Cancro,
c/o Centro Biotecnologie Avanzate, Torre B - Piano 2
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Tel: +39-0105558-289, Fax: +39-0105558-293
Email: assunta.manniello@istge.it